Saturday, April 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

Deutsche Pfandbriefbank Shares Plunge on Catastrophic Annual Results

Rodolfo Hanigan by Rodolfo Hanigan
March 9, 2026
in Banking & Insurance, Earnings, Real Estate & REITs, Turnaround
0
Deutsche Pfandbriefbank Stock
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

Investors in Deutsche Pfandbriefbank (PBB) faced a brutal reckoning as the German commercial property lender released its 2025 figures. The report revealed a staggering net loss of 284 million euros, triggering a collapse in the share price to a multi-year low. The bank’s foray into the United States market, which ended in a full retreat, has proven extraordinarily costly.

Strategic Misstep Leads to Deep Losses

A failed expansion into the US commercial real estate sector lies at the heart of the bank’s troubles. Initiated just before the pandemic, the timing could hardly have been worse. The collapse in office demand during COVID-19 plunged numerous property investors and their financiers into crisis. The decision to completely exit this loss-making American business in 2025 ripped a 284-million-euro hole in the annual accounts, swinging the bank from a 90-million-euro profit the previous year deep into the red.

Provisions for bad loans skyrocketed to 410 million euros, a dramatic increase from 170 million euros in 2024, reflecting the severe stress in the portfolio.

Shareholder Payout Axed and Targets Pushed Back

In a double blow for shareholders, the bank’s dividend has been eliminated entirely. This follows a payout of 0.15 euros per share for the prior year. CEO Kay Wolf, who took the helm from long-time chief Andreas Arndt in early 2024, acknowledged a protracted restructuring lies ahead. “The transformation is significantly more substantial and will therefore take longer,” Wolf stated.

Wolf had already discarded his predecessor’s medium-term plans in autumn 2024, setting more modest goals before initiating the full US withdrawal in 2025. The bank has now formally delayed its key profitability target, pushing the goal for an 8% return on equity back by one year to 2028.

Should investors sell immediately? Or is it worth buying Deutsche Pfandbriefbank?

Cautious Guidance Disappoints the Market

The outlook for 2026 offered little solace to disappointed analysts. Management forecasts operating income between 375 and 425 million euros, trending below the 2025 figure of 422 million. The bank cited a slow recovery in European property markets and the ongoing costs of the US exit as burdens, noting that new business in Europe can only gradually compensate for the lost US loan book.

Pre-tax profit is projected to land between 30 and 40 million euros, a figure that falls sharply short of market expert expectations, which had centered on over 100 million euros. The complete annual report for 2025 is scheduled for publication on 23 March.

Equity Value Evaporates in Sustained Sell-Off

The market’s reaction to the news was swift, with shares tumbling 6.5%. Since the start of the year, the SDAX-listed stock has shed more than a quarter of its value. Over a three-year period, the cumulative loss exceeds two-thirds. The share price hit a 52-week low of 3.30 euros on 4 March, a stark contrast to its all-time high of 15.65 euros reached in February 2020.

The bank aims to nearly double its earnings to approximately 600 million euros by 2028. This ambition follows a deeply negative return on tangible equity of minus 10.6% for the past year, underscoring the scale of the challenge now facing management.

Ad

Deutsche Pfandbriefbank Stock: Buy or Sell?! New Deutsche Pfandbriefbank Analysis from April 11 delivers the answer:

The latest Deutsche Pfandbriefbank figures speak for themselves: Urgent action needed for Deutsche Pfandbriefbank investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 11.

Deutsche Pfandbriefbank: Buy or sell? Read more here...

Tags: Deutsche Pfandbriefbank
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

April 11, 2026
BioNTech Stock
Earnings

BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

April 11, 2026
Fermi Stock
Analysis

Fermi’s Texas Power Gamble Faces Investor Exodus and Delays

April 10, 2026
Next Post
Nokia Stock

Institutional Investor Confidence Rises as Nokia Charts AI-Driven Course

Carl Zeiss Meditec Stock

Carl Zeiss Meditec Faces Market Downgrade Amid Operational Challenges

Aurubis Stock

Aurubis Shares Face Scrutiny After Fatal Plant Incident

Recommended

Infineon Stock

Infineon’s Strategic Pivot Amid Rising Asian Competition in Power Semiconductors

3 weeks ago
Asbury Automotive Stock

Asbury Automotive’s Expansion Strategy Faces Market Skepticism

8 months ago
ePlus Stock

ePlus Stock: A Quiet Transformation Gains Momentum

7 months ago
Rimini Stock

Rimini Street Stock: Executive Sales Cloud Strong Growth Narrative

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

Fermi’s Texas Power Gamble Faces Investor Exodus and Delays

iShares MSCI World ETF: Stability Anchored by a Handful of Tech Titans

Coinbase Faces a Volatility Trap as Trading Slumps and New Products Launch

Ams Osram’s Gold Problem Meets AI Optimism

Trending

ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

by Jackson Burston
April 11, 2026
0

ImmunityBio's stock is navigating a volatile path, caught between explosive commercial growth for its bladder cancer drug...

Strategy Stock

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

April 11, 2026
BioNTech Stock

BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

April 11, 2026
Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

April 11, 2026
Orora Stock

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

April 10, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ImmunityBio’s Record Revenue Meets Mounting Legal Pressure
  • Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction
  • BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com